======= ERLIN2 ======= == Gene Information == * **Official Symbol**: ERLIN2 * **Official Name**: ER lipid raft associated 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11160|11160]] * **UniProt**: [[https://www.uniprot.org/uniprot/O94905|O94905]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ERLIN2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ERLIN2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611605|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the SPFH domain-containing family of lipid raft-associated proteins. The encoded protein is localized to lipid rafts of the endoplasmic reticulum and plays a critical role in inositol 1,4,5-trisphosphate (IP3) signaling by mediating ER-associated degradation of activated IP3 receptors. Mutations in this gene are a cause of spastic paraplegia-18 (SPG18). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2012]. * **UniProt Summary**: Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs) such as ITPR1 (PubMed:19240031, PubMed:17502376). Promotes sterol-accelerated ERAD of HMGCR probably implicating an AMFR/gp78-containing ubiquitin ligase complex (PubMed:21343306). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. May promote ER retention of the SCAP-SREBF complex (PubMed:24217618). {ECO:0000269|PubMed:17502376, ECO:0000269|PubMed:19240031, ECO:0000269|PubMed:21343306, ECO:0000269|PubMed:24217618}. |Band 7| |negative regulation of cholesterol metabolic process| |negative regulation of sterol biosynthetic process| |negative regulation of cholesterol biosynthetic process| |SREBP signaling pathway| |cellular response to sterol depletion| |response to sterol depletion| |negative regulation of alcohol biosynthetic process| |negative regulation of fatty acid biosynthetic process| |negative regulation of steroid biosynthetic process| |negative regulation of steroid metabolic process| |negative regulation of fatty acid metabolic process| |ER-nucleus signaling pathway| |regulation of sterol biosynthetic process| |regulation of cholesterol biosynthetic process| |regulation of fatty acid biosynthetic process| |negative regulation of lipid biosynthetic process| |cholesterol binding| |regulation of cholesterol metabolic process| |ubiquitin-dependent ERAD pathway| |regulation of alcohol biosynthetic process| |negative regulation of lipid metabolic process| |regulation of fatty acid metabolic process| |regulation of steroid biosynthetic process| |ERAD pathway| |negative regulation of small molecule metabolic process| |regulation of steroid metabolic process| |cholesterol metabolic process| |secondary alcohol metabolic process| |sterol metabolic process| |regulation of cellular ketone metabolic process| |regulation of lipid biosynthetic process| |membrane raft| |response to endoplasmic reticulum stress| |steroid metabolic process| |ubiquitin protein ligase binding| |alcohol metabolic process| |proteasome-mediated ubiquitin-dependent protein catabolic process| |proteasomal protein catabolic process| |regulation of lipid metabolic process| |regulation of small molecule metabolic process| |organic hydroxy compound metabolic process| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |protein-containing complex| |cellular protein catabolic process| |protein catabolic process| |cellular macromolecule catabolic process| |endoplasmic reticulum membrane| |response to organonitrogen compound| |endoplasmic reticulum| |macromolecule catabolic process| |organonitrogen compound catabolic process| |response to nitrogen compound| |lipid metabolic process| |positive regulation of transcription by RNA polymerase II| |proteolysis| |transmembrane transport| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular response to stress| |positive regulation of RNA metabolic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp52|Ribavirin 10μM R01 exp52]]|-3.05| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.75| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|-1.74| |[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.37| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4546 * **Expression level (log2 read counts)**: 5.89 {{:chemogenomics:nalm6 dist.png?nolink |}}